All Stories

  1. Acute kidney injury after radial or femoral artery access in ST-segment elevation myocardial infarction: AKI-SAFARI
  2. Performance of Plasma Adenosine as a Biomarker for Predicting Cardiovascular Risk
  3. A Novel Protocol for Very Early Hospital Discharge After STEMI
  4. A Shifting Paradigm
  5. Contrast-free optical coherence tomography:Systematic evaluation of non-contrast media for intravascular assessment
  6. Evaluation of plasminogen activator inhibitor-1 as a biomarker of unplanned revascularization and major adverse cardiac events in coronary angiography and percutaneous coronary intervention
  7. Radial access first for PCI in acute coronary syndrome
  8. Imaging the Left Atrial Appendage
  9. Comparative Accuracy of Focused Cardiac Ultrasonography and Clinical Examination for Left Ventricular Dysfunction and Valvular Heart Disease
  10. Evaluation of Plasma Adenosine as a Marker of Cardiovascular Risk: Analytical and Biological Considerations
  11. Female Authorship in Preclinical Cardiovascular Research
  12. Adenosine as a Marker and Mediator of Cardiovascular Homeostasis: A Translational Perspective
  13. Training Cardiology Fellows in Focused Cardiac Ultrasound
  14. Left Atrial Appendage Occlusion Guided by Intracardiac Echocardiography from the Right Ventricular Outflow Tract
  15. In-hospital outcomes of STEMI patients on warfarin undergoing primary PCI
  16. The Next Generation of Physician-Scientists: Adapting to Academic Cardiology in the 21st Century
  17. Optimal mean arterial pressure in comatose survivors of out-of-hospital cardiac arrest: An analysis of area below blood pressure thresholds
  18. The Impact of a Transition of Care Program on Acute Myocardial Infarction Readmission Rates
  19. Predicting Acute Kidney Injury following Transcatheter Aortic Valve Replacement
  20. Effect of a Formalized Research Curriculum on Fellows-in-Training and Early Career Research Productivity
  21. Multiple inappropriate implantable cardiac defibrillator therapies in rapid succession
  22. Novel Treatments for Familial Hypercholesterolemia: Pharmacogenetics at Work